Invest Now ! 

Sangre BioSciences

Sangre BioSciences is currently in the process of conducting a comprehensive Cannabis Genome Study to complete a global genomic classification of the cannabis plant genus. Sangre BioSciences is focused on a genomics based cannabis breeding program that will produce new, genetically enhanced strains of cannabis that express the desired plant characteristics for strain specific and disease specific treatments and therapies for both humans and animals.


Be the first to receive the latest Industry and WEED INC. News & Updates.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram